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C. elegans RPM-1 (for Regulator of Presynap-
tic Morphology) is a member of a conserved
protein family that includes Drosophila High-
wire and mammalian Pam and Phr1. These
are large proteins recently shown to regulate
synaptogenesis through E3 ubiquitin ligase ac-
tivities. Here, we report the identification of an
RCC1-like guanine nucleotide exchange fac-
tor, GLO-4, from mass spectrometry analysis
of RPM-1-associated proteins. GLO-4 colocal-
izes with RPM-1 at presynaptic terminals. Loss
of function in glo-4 or in its target Rab GTPase,
glo-1, causes neuronal defects resembling
those in rpm-1 mutants. We show that the
glo pathway functions downstream of rpm-1
and acts in parallel to fsn-1, a partner of
RPM-1 E3 ligase function. We find that late en-
dosomes are specifically disorganized at the
presynaptic terminals of glo-4 mutants. Our
data suggest that RPM-1 positively regulates
a Rab GTPase pathway to promote vesicular
trafficking via late endosomes.
INTRODUCTION
Chemical synapses relay information from one neuron to
the next, allowing an organism to register and respond
to its external environment. The synapse is composed of
a presynaptic specialization where synaptic vesicle (SV)
exocytosis and neuorotransmitter release occur, and an
opposing postsynaptic terminal where neurotransmitters
bind to receptors that initiate intracellular signals. The or-
ganization of both presynaptic and postsynaptic terminals
is essential for proper synaptic function (Waites et al.,
2005).Presynaptic differentiation requires a series of vesicular
and cytoskeletal changes (Murthy and De Camilli, 2003;
Waites et al., 2005). One family of molecules known to
regulate vesicle and membrane dynamics is the Rab
GTPases. Rabs function as molecular switches that cycle
between a GDP-bound ‘‘inactive’’ form, and a GTP-bound
‘‘active’’ form that binds to effector proteins to modulate
vesicle dynamics (Collins, 2003; Zerial and McBride,
2001). Many Rabs are present at the presynaptic terminal
(Takamori et al., 2006). However, with the exception of
Rab3a, the precise roles of most Rabs at the synapse
are unclear (Sudhof, 2000).
One particular process that involves Rab GTPases is
endocytosis. At synapses, endocytosed SVs often traffic
through the early and the recycling endosomal compart-
ments before reentering the SV pool (Sudhof, 2000). The
later compartments in the endocytic pathway, such as
the late endosome/lysosome, have been mostly impli-
cated in neurodegenerative diseases such as Alzhei-
mer’s disease (Nixon et al., 2000). A few studies have
suggested that late endocytic compartments may reg-
ulate normal presynaptic development and function. In
the avian brain, lysosomes are accumulated in transient
nascent synapses (Teuchert-Noodt et al., 1991). Exocy-
tosis of late endosomes/lysosomes involving calcium
and synaptotagmin (SNT) VII promotes neurite extension
of primary sympathetic neurons (Arantes and Andrews,
2006). Late endosomes/lysosomes are also present at
the nodes of Ranvier in motor axons (Gatzinsky and Bert-
hold, 1990; Gatzinsky et al., 1991; Overly and Hollen-
beck, 1996). Importantly, genetic studies in Drosophila
have shown that mutations in the spinster/benchwarmer
gene, which encodes a late endosomal/lysosomal mem-
brane protein, cause increased numbers of presynaptic
boutons and reduced presynaptic neurotransmitter
release at neuromuscular junctions (NMJs) (Dermaut
et al., 2005; Nakano et al., 2001; Sweeney and Davis,
2002). There is also an expansion of late endosomes/
lysosomes at these synapses (Sweeney and Davis,
2002). Spinster localization is regulated by shrub,Neuron 55, 587–601, August 16, 2007 ª2007 Elsevier Inc. 587
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for transport (ESCRT)-III that functions in axon branch
specification (Sweeney et al., 2006). However, the role
and regulation of the late endosome/lysosome in pre-
synaptic differentiation are largely unexplored.
Pam/Highwire/RPM-1 (PHR) proteins have essential
roles in presynaptic differentiation and function in rodents
(Burgess et al., 2004; Ehnert et al., 2004), fish (D’Souza
et al., 2005), flies (Wan et al., 2000), and worms (Schaefer
et al., 2000; Zhen et al., 2000). PHR proteins are large mol-
ecules that contain multiple conserved functional domains
(see illustration in Figure 1A). PHR proteins contain at their
N termini an RCC1-like domain (RLD) that may function as
a guanine nucleotide exchange factor (GEF). The middle
portion of PHR proteins contains motifs that are highly
conserved within the PHR family, but which are not homol-
ogous to any known functional domains. The C termini of
PHR proteins contain a RING-H2 domain that is a hallmark
of E3 ubiquitin ligases, and recent studies have shown that
PHR proteins have E3 ligase activity. C. elegans RPM-1 is
a component of a Skp/Cullin/F-box (SCF) protein complex
containing SKR-1, CUL-1, and the F-box synaptic protein
FSN-1 (Liao et al., 2004). One target of the RPM-1 ubiqui-
tin ligase activity is the dual leucine zipper-bearing kinase
(DLK)-1, which activates MKK-4 MAPKK and PMK-3,
a p38 MAP kinase (Nakata et al., 2005). In Drosophila,
Hiw acts to inhibit the Wallenda DLK, which acts through
c-Jun N-terminal kinase (JNK) to regulate gene transcrip-
tion via the c-Fos transcription factor (Collins et al., 2006).
Aside from their ubiquitin ligase activity, however, little is
known about the other functions of PHR proteins. The
RLD-containing region of Pam inhibits adenylate cyclase
activity in vitro (Scholich et al., 2001). Although anti-sense
against Pam/Phr enhances adenylate cyclase activity in
rats and increases nociceptive behavior (Ehnert et al.,
2004), a link between the inhibition of adenylate cyclase
by Pam and synaptic function has yet to be shown.
We have taken a biochemical approach to dissect
RPM-1 signaling pathways. Complete loss of function in
rpm-1 causes a range of defects. The motor neurons
form fewer synapses, and the remaining synapses have
disorganized architecture (Nakata et al., 2005; Zhen
et al., 2000). The mechanosensory neurons fail to form
stable synaptic branches, and overextend their axons
(Schaefer et al., 2000). However, complete loss of func-
tion in fsn-1, a component of the RPM-1 E3 ligase com-
plex, causes defects similar to, but weaker than, those
caused by rpm-1/ (Liao et al., 2004), indicating that
other molecules may function together with rpm-1. We
here report the identification of a Rab GEF, known as
GLO-4, as an RPM-1 interacting protein. We show that
GLO-4 and its target Rab, GLO-1, act in a linear pathway
downstream of RPM-1 to regulate axon termination and
synaptogenesis. In glo-4 mutants, late endosomes are
specifically altered at presynaptic terminals. Our findings
suggest that one mechanism by which RPM-1 promotes
presynaptic differentiation is through regulation of vesicle
trafficking.588 Neuron 55, 587–601, August 16, 2007 ª2007 Elsevier Inc.RESULTS
Biochemical Identification of an RLD-Containing
GEF, GLO-4, as an RPM-1 Binding Protein
To identify signaling pathways regulated by RPM-1, we
performed a biochemical assay to search for RPM-1 inter-
acting proteins (Figure 1B). We used a transgenic line
(juIs58) expressing RPM-1 fused with green fluorescent
protein (RPM-1::GFP) that is localized to synapses and
which fully rescues the synaptic defects of rpm-1/ mu-
tants (Zhen et al., 2000). RPM-1::GFP is produced as
a high molecular weight fusion protein (approximately
450 kDa) (Figure 1C top and bottom panel).
We optimized our protein extraction procedure to max-
imize the detection of synaptic proteins (see Experimental
Procedures). We immunoprecipitated RPM-1::GFP from
whole worm lysates using an anti-GFP antibody. An equal
amount of total protein from wild-type animals was immu-
noprecipitated in parallel as a negative control. We used
mass spectrometry to identify peptides specific to the
RPM-1::GFP sample (Experimental Procedures). One set
of peptides corresponded to the known RPM-1 associ-
ated protein FSN-1 (Liao et al., 2004), validating our meth-
odology. Among other RPM-1 interacting proteins we
consistently identified GLO-4, a putative GEF.
GLO-4 contains an RLD related to those of Drosophila
Claret, human retinitis pigmentosa GTPase regulator
(RPGR), and human deafness associated locus (Del)
GEF (Figure 1D and Figure S1 in the Supplemental Data
available with this article online). The RLD is predicted to
have a seven-bladed, propeller-like structure similar to
that of RCC1, the GEF for the GTPase Ran (Renault
et al., 1998). All four proteins contain a contiguous series
of seven RCC1-like repeats (Figure S1). Among them,Dro-
sophila Claret has been shown to bind preferentially to
a GDP-bound form of the Rab GTPase Lightoid (Ma
et al., 2004). Previous studies have shown that glo-4 func-
tions in the biogenesis of gut granules, which are lyso-
some-related organelles (LROs) (Hermann et al., 2005). A
deletion allele of glo-4, ok623, truncates the GLO-4 protein
preceding its RLD domain (Figure 1E), and behaves genet-
ically as a null mutation (see Experimental Procedures),
suggesting that the RLD domain is critical for GLO-4 func-
tion. glo-4 mutants lack such gut granules (Figure 1F),
hence the name gut granule loss (Glo) mutants.
RPM-1 Interacts with GLO-4 Independently
of the RING Domain
To confirm that GLO-4 binds to RPM-1 in neurons, we
generated transgenic animals expressing GLO-4 tagged
at its N terminus with a FLAG epitope (FLAG::GLO-4)
driven by the panneuronal promoter of the gene F25B3.3
in an RPM-1::GFP background. We immunoprecipitated
FLAG::GLO-4 with anti-FLAG antibody from whole worm
extracts and probed immunoblots with anti-GFP antibody
to detect coprecipitating RPM-1::GFP. In agreement with
our mass spectrometry experiments, we observed copre-
cipitation of FLAG::GLO-4 and RPM-1::GFP (Figure 1C).
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Regulation of a Vesicular Pathway by RPM-1Figure 1. Identification of GLO-4 as an RPM-1 Interaction Partner
(A) Schematic representation of RPM-1 domain organization. RLD, RCC1-like domain; PHR, Pam/Highwire/RPM-1 family-specific domains; RING,
RING-H2 ubiquitin ligase domain. Amino acid 2439 marks the C-terminal deletion.
(B) Scheme of the methodology used to identify RPM-1 binding proteins from C. elegans lysates.
(C and D) CoIP of full-length RPM-1::GFP (juIs58) or RPM-1(1-2439)::GFP (juEx1093) with PF25B3.3FLAG::GLO-4 (juEx1349). FLAG-GLO-4 was immu-
noprecipitated from C. elegans protein lysates and immunoblotted with an anti-GFP antibody to detect coprecipitating RPM-1::GFP (C) or RPM-1(1-
2439)::GFP (D) (top panels). The blots were stripped and reprobed with anti-FLAG antibody to detect FLAG-GLO-4 (middle panels). Input RPM-
1::GFP or RPM-1(1-2439)::GFP was precipitated with anti-GFP antibody and blotted with anti-GFP antibody (left lane of top panels and bottom panel
for [C], and second panel from bottom for [D]). For (D), a blot of whole worm lysate with anti-ERK rabbit polyclonal antisera is shown (bottom panel).
(E) GLO-4 homologous proteins containing a single RLD. glo-4(ok623) is a deletion mutation that leads to a premature stop codon after Ile621.
(F) (Left) Fluorescence microscopy showing autofluorescent gut granules in live, adult N2 animals and their complete absence in glo-4mutants. (Right)
Quantitative analysis of the rescue of the Glo phenotype in glo-4 mutants expressing GLO-4::GFP driven by the glo-4 promoter.RPM-1 contains a RING domain at its C terminus that is
involved in ubiquitin-mediated protein degradation (Liao
et al., 2004; Nakata et al., 2005). We next addressedNwhether GLO-4 binding to RPM-1 involved this domain.
We generated transgenic animals coexpressing FLAG::
GLO-4 with a truncated RPM-1 consisting of amino acidseuron 55, 587–601, August 16, 2007 ª2007 Elsevier Inc. 589
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Regulation of a Vesicular Pathway by RPM-1Figure 2. GLO-4 Is Expressed in the
Nervous System and Colocalizes with
RPM-1
(A and B) Confocal images of adult animals ex-
pressing GLO-4::GFP costained with anti-GFP
(green) and anti-SNT-1 (red in A), or anti-RPM-
1 (red in B). All are wild-type animals except
where indicated. GLO-4::GFP colocalized
with RPM-1, but not SNT, in both SAB neu-
rons and ventral nerve cord. The pattern of
GLO-4::GFP in the ventral cord was unaltered
in rpm-1/.
(C) Confocal images of adult animals coex-
pressing Punc-25Cherry::GLO-4 (juEx1448)
(red), and Punc-25RPM-1::GFP (juIs77) (green).
(D) Confocal images of adult wild-type and
glo-4/ animals costained for endogenous
RPM-1 (red) or endogenous RIM (green).
RPM-1 localization was unaltered in glo-4/.
Scale bars, 2 mm.1–2439, tagged with GFP. We found that this N-terminal
portion of RPM-1 and FLAG::GLO-4 coimmunoprecipi-
tated (Figure 1D). Taken together, these findings indicate
that GLO-4 and RPM-1 are physically associated in neu-
rons, independent of the RPM-1 RING domain.
GLO-4 Colocalizes with RPM-1
at the Presynaptic Terminal
To address where GLO-4 is localized, we examined its ex-
pression using a functional C-terminal fusion of GLO-4
and GFP (Figure 1F, see Experimental Procedures).
GLO-4::GFP showed a discrete punctate localization in
many different tissues, including muscle, pharynx, gut
(data not shown), and nervous system (Figure 2). To deter-
mine if GLO-4::GFP was localized at the synapse, we per-
formed coimmunostaining and found that in the ventral
nerve cord, GLO-4::GFP was localized to discrete puncta
adjacent to the SV protein SNT-1 (Figure 2A). In the cholin-
ergic SAB motor neurons, GLO-4::GFP was localized at
the anterior tip of the axon, while SNT-1 was localized at
puncta throughout the length of the axon and excluded
from the tip (Figure 2A). This localization pattern is very
similar to that of RPM-1 (Nakata et al., 2005). We coim-
munostained GLO-4::GFP and endogenous RPM-1 and590 Neuron 55, 587–601, August 16, 2007 ª2007 Elsevier Inc.observed significant colocalization in the ventral cord,
especially in regions that had high expression of RPM-1
(Figure 2B). Similarly, in the SAB neurons, GLO-4::GFP
and RPM-1 colocalized at the anterior tip of the axon,
where RPM-1 is most concentrated (Figure 2B) (B.
Abrams and Y.J., unpublished data). To further confirm
the colocalization of these two proteins at individual syn-
apses in another type of neuron, we expressed RPM-
1::GFP and Cherry::GLO-4 in the type D GABAergic motor
neurons using the unc-25 promoter. The D neurons form
en passant synapses along the dorsal and ventral nerve
cords (White et al., 1986). We found that Cherry::GLO-4
and RPM-1::GFP colocalized to distinct puncta in the
axons of these neurons (Figure 2C).
The interaction between GLO-4 and RPM-1 could play
a role in the synaptic localization of these proteins through
recruitment or stabilization. To address this, we examined
GLO-4::GFP in rpm-1 mutants. In the nerve cords of these
animals, GLO-4::GFP was localized to discrete puncta
adjacent to SNT-1 puncta. Both the pattern and in-
tensity were similar to those in wild-type animals
(Figure 2A). Conversely, we examined the localization of
endogenous RPM-1 in glo-4 mutants. RPM-1 was local-
ized in a punctate pattern adjacent to the active zone
Neuron
Regulation of a Vesicular Pathway by RPM-1protein RIM/UNC-10 (Figure 2D) or SNT-1 (data not
shown) in the nerve cords, similar to wild-type animals.
Thus, the synaptic localization of GLO-4 and RPM-1
occurs independently of one another.
glo-4 Regulates Axon Termination
in Mechanosensory Neurons
We assessed the function of glo-4 in neurons using a panel
of neuronal markers. In glo-4/ mutants, the axon mor-
phology of ventral cord motor neurons and HSN neurons
was grossly normal (data not shown). However, several
of the mechanosensory neurons and CAN neurons
showed defects in axon termination similar to those in
rpm-1/ mutants (Figure 3 and Figure S2).
In wild-type animals, the ALM mechanosensory neu-
rons have their cell bodies situated at the midanterior of
the body and extend a single axon anteriorly that termi-
nates a significant distance from the end of the nose (Fig-
ure 3A). In glo-4/ animals, over 80% of ALM axons over-
extended to the end of the nose, and some of these axons
folded and grew posteriorly, resulting in a ‘‘hook’’ shape
(Figures 3A and 3B). These defects resemble those of
rpm-1/ mutants (Figures 3A and 3B) (Schaefer et al.,
2000). Previous studies have shown that the termination
of the ALM axon is a temperature-sensitive process
(Schaefer et al., 2000). Similar to rpm-1/, the penetrance
of ALM defects in glo-4/ mutants was increased at 25C
compared with 22.5C (Figure 3B).
The cell bodies of the PLM mechanosensory neurons
are situated at the posterior end of the animal and extend
a single process toward the anterior that normally termi-
nates just before the ALM cell bodies (Figure 3C). In
glo-4/ mutants, PLM axons overextended in a similar
manner to those in rpm-1/ mutants, with the PLM
axon extended past the ALM cell body and hooked toward
the ventral nerve cord (hook and extension) (Figures 3C
and 3D). This phenotype was highly penetrant in rpm-1/
mutants and occurred at a much lower frequency in
glo-4/ animals (Figure 3D). A milder, but more pene-
trant, defect was seen in glo-4/ mutants, in which the
PLM axon extended beyond the ALM cell body without
hooking into the ventral nerve cord (extension only) (Fig-
ures 3C and 3D).
The longitudinal axons of PLM neurons normally ex-
tend a branch toward the ventral cord and form synapses
onto several neurons (White et al., 1986) (Figure 3E). In
rpm-1/ mutants, the PLM synaptic branch failed to ex-
tend from the main axonal process (Figures 3E and 3F).
This defect was rarely seen in glo-4/ mutants. We ob-
served a similar range of ALM and PLM defects using
a second transgenic marker for the touch neurons,
Pmec-4GFP (zdIs5) (data not shown), indicating that the dif-
ference in penetrance is not due to the transgenic back-
ground. As shown below, expression of the genomic
glo-4 DNA fully rescued these defects in touch neurons,
indicating that a loss of glo-4 function is responsible for
these phenotypes.glo-4 Functions in Parallel to fsn-1 to Regulate
Axon Termination
Because glo-4/ only partially phenocopy rpm-1/ phe-
notypes, it is possible that GLO-4 is only one of several
molecules mediating the function of RPM-1. Thus, other
RPM-1 binding partners might show a similar but milder
phenotype to rpm-1/. One such candidate is the FSN-
1 F-box protein that is part of an SCF complex containing
RPM-1 (Liao et al., 2004). We found that complete loss of
function in fsn-1 resulted in weak defects in the ALM and
PLM neurons (Figure 3). To test whether glo-4 and fsn-1
might each mediate a portion of rpm-1 function, we con-
structed fsn-1/; glo-4/. The penetrance of defects in
PLM axon termination and synaptic branch extension in
the double mutants was significantly enhanced relative
to the single mutants, and was not significantly different
from those in rpm-1/ mutants (Figures 3B and 3D).
These observations are consistent with glo-4 and fsn-1
functioning in parallel genetic pathways to mediate rpm-
1 function in PLM neurons.
To test further if glo-4 acts independently of the RPM-
1/FSN-1-mediated ubiquitination pathway, we asked
how glo-4 might interact with dlk-1, which encodes the
dual leucine zipper-bearing kinase and is a target of
RPM-1’s ubiquitin ligase activity (Nakata et al., 2005).
We found that loss of function of dlk-1 strongly, but not
completely, suppressed the defects in the ALM and
PLM neurons in rpm-1/ mutants (Figures 3B, 3D, and
3F), consistent with our previous observations that
dlk-1/ suppresses the motor synapse defects of rpm-
1/ (Nakata et al., 2005). However, the defects in the
ALM and PLM neurons in glo-4/ mutants were not
suppressed by dlk-1/. Moreover, the defects that
remained in dlk-1/; rpm-1/ were similar to those of
glo-4/ mutants (Figures 3B, 3D, and 3F). Thus, this anal-
ysis suggests that only the effects of loss of RPM-1 ubiqui-
tin ligase activity can be rescued by loss of DLK-1 activity,
whereas the remaining defects in dlk-1/; rpm-1/
reflect loss of glo-4 function.
glo-4 and fsn-1 Function in Parallel to Regulate
Motor Neuron Synaptogenesis
To address if the parallel interactions between glo-4 and
fsn-1 occur in other cellular processes regulated by
rpm-1, we next analyzed the GABAergic motor neuron
synapses. In these neurons, an SV marker, Punc-25SNB-
1::GFP (juIs1), shows discrete fluorescent puncta in the
dorsal and ventral nerve cords where synapses are
formed by the DD and VD motor neurons, respectively
(Hallam and Jin, 1998) (Figure 4A). In rpm-1/ mutants
there are fewer SNB-1::GFP puncta, and these puncta
are also disorganized (Zhen et al., 2000) (Figure 4A). glo-
4/ mutants showed no obvious defects in the localiza-
tion of SNB-1::GFP. In fsn-1/ mutants, the SNB-
1::GFP puncta in the VD neurons were largely normal,
but those in DD neurons exhibited mild irregularities simi-
lar to, albeit weaker than, those displayed by rpm-1/
mutants. However, in fsn-1/; glo-4/, the morphologyNeuron 55, 587–601, August 16, 2007 ª2007 Elsevier Inc. 591
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Regulation of a Vesicular Pathway by RPM-1Figure 3. glo-4 Mutants Have Defects in Axon Termination Resembling Those of rpm-1 Mutants
(A, C, and E) ALM and PLM mechanosensory neurons were visualized using muIs32[Pmec-7GFP] in wild-type or the indicated mutant genotypes.
(A) Axon termination defects in the ALM neuron. (C) Axon termination defects in the PLM neuron. Arrowheads highlight extension and hooking of
the PLM axon toward the ventral nerve cord, and arrows highlight extension of the PLM axon beyond the ALM cell body. (E) Absence of a synaptic
branch extended from the PLM neuron. The asterisk highlights the PLM synaptic branch, and the arrow highlights its absence. Analysis was per-
formed on young adult animals grown at 22.5C unless otherwise specified. Images in (A), (C), and (E) correspond with boxed regions of diagrams;
anterior is to the left. Scale bars, 10 mm. (B, D, and F) Quantitation of the defects in mechanosensory neurons. (B) Defects in axon termination in ALM
neurons, (D) defects in axon termination in PLM neurons, and (F) defects in synaptic branch extension in PLM neurons. The anaplastic lymphoma
kinase (ALK/SCD-2) was also identified as a target for RPM-1/FSN-1 ubiquitin ligase activity (Liao et al., 2004). No suppression of rpm-1/ defects
in ALM and PLM neurons was seen by scd-2 (B and D), consistent with our previous observations on motor neuron synapses (Nakata et al., 2005). Not
significant (ns) p > 0.05; *p < 0.05, **p < 0.005, ***p < 0.001, determined using a Student’s t test.of SNB-1::GFP puncta in both DD and VD neurons was se-
verely disrupted. Quantitation of the synaptic puncta
showed no significant difference between rpm-1/ and592 Neuron 55, 587–601, August 16, 2007 ª2007 Elsevier Incfsn-1/; glo-4/ (Figure 4B). We conclude that glo-4
and fsn-1 act in parallel to mediate the function of rpm-1
in motor neuron synaptogenesis..
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Regulation of a Vesicular Pathway by RPM-1Figure 4. glo-4 Mutation Enhances
Motor Synapse Defects in fsn-1Mutants
(A) GABAergic presynaptic terminals were
visualized using juIs1[Punc-25SNB-1::GFP] in
dorsal cord and ventral cord in wild-type or
the indicated mutant genotypes. Asterisks
highlight abnormally aggregated puncta and
arrows highlight gaps in puncta.
(B) Quantitation of the SNB-1::GFP puncta
number in the VD5 neuron. Analysis was
performed on young adult animals grown
at 25C. Scale bar, 10 mm. ns p > 0.05;
***p < 0.001 by Student’s t test.The GLO-1 Rab GTPase and AP-3 Regulate Axon
Termination in a Common Pathway with GLO-4
The Rab GTPase GLO-1 is thought to act as a GLO-4 tar-
get in gut granule biogenesis (Hermann et al., 2005).
GLO-1 is the sole C. elegans member of a Rab subfamily
that includes vertebrate Rab32, Rab38, and Rab7-like var-
iant 1 (Rab7L1). Drosophila Lightoid, a GLO-1 ortholog,
has been shown to interact with Claret, the GLO-4 ortho-
log (Ma et al., 2004). We therefore tested whether glo-1 is
involved in glo-4 and rpm-1 function in neurons. We found
that in both glo-1(zu437) and glo-1(zu391) mutants, the
mechanosensory neurons overextended their axons (Fig-
ure 5; data not shown for zu437), but the defects were less
penetrant than those in rpm-1/ or glo-4/. To deter-
mine if glo-1 functions in a manner similar to glo-4/,
we examined fsn-1/; glo-1/ and found that they dis-
played strong enhancement of ALM and PLM defects
compared with either single mutant (Figure 5). However,
the penetrance of defects in fsn-1/; glo-1/ remained
lower than that of fsn-1/; glo-4/. glo-1/ did not en-
hance the touch neuron defects of glo-4 single mutants at
25C, confirming that glo-1 and glo-4 act in a linear path-
way in neuronal development (Figure 5). Because glo-
1(zu437) is a molecular null mutation (Hermann et al.,N2005), our observations suggest that GLO-1 may act re-
dundantly with other unidentified GTPases to mediate
GLO-4 function in these neurons.
To address further if glo-4 and glo-1 act in the same
pathway as rpm-1, we generated rpm-1/; glo-1/
and rpm-1/ glo-4/. The touch neuron axon extension
defects in these double mutants were indistinguishable
from those in rpm-1 single mutants (Figure 5). The motor
neuron synapse defects in rpm-1/ glo-4/ were also
indistinguishable from those in rpm-1/ single mutants
(Figure 4B). These findings are consistent with glo-4 and
glo-1 acting in the same pathway as rpm-1.
Since mutants in subunits of the AP-3 adaptor complex
exhibit a Glo phenotype (Hermann et al., 2005), we next
tested if AP-3 might be involved in glo-4 function in neu-
rons. We found that apm-3(tm920) mutants had defects
in both the ALM and PLM neurons resembling those of
glo-1/ mutants in severity (Figure 5). Loss of apm-3
function did not enhance the mechanosensory neuron de-
fects of glo-4/ mutants, consistent with apm-3 and glo-
4 acting in the same pathway. Because glo-4, glo-1, and
apm-3 function in the biogenesis of lysosome-like organ-
elles in the gut (Hermann et al., 2005), the failure of axon
termination might be explained by a loss of lysosomeeuron 55, 587–601, August 16, 2007 ª2007 Elsevier Inc. 593
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Regulation of a Vesicular Pathway by RPM-1Figure 5. glo-4 Acts through glo-1 and apm-3 to Regulate Axon Termination
Quantitation of touch neuron defects in wild-type or the indicated mutant genotypes.
(A) Defects in axon termination in ALM neurons.
(B) Defects in axon termination in PLM neurons. We analyzed young adult animals grown at 22.5C, unless otherwise specified. ns p > 0.05; *p < 0.05,
**p < 0.005, ***p < 0.001 by Student’s t test.function. To test this hypothesis we examined animals
lacking the mucolipin-1 ortholog CUP-5, a protein shown
to be essential for lysosome function (Fares and Green-
wald, 2001; Treusch et al., 2004). We found that cup-5/
mutants showed normal ALM and PLM axon termination
patterns (Figure 5). This result suggests that axon termina-
tion defects are not caused simply by a loss of lysosome
function.
glo-4 and glo-1 Function Cell-Autonomously
Downstream of rpm-1
rpm-1 acts cell-autonomously in the touch neurons
(Schaefer et al., 2000). To ascertain if glo-4 and glo-1
are also acting cell-autonomously, we performed trans-594 Neuron 55, 587–601, August 16, 2007 ª2007 Elsevier Inc.genic rescue of these mutants with cell-specific pro-
moters driving glo-4 or glo-1. Expression of glo-4 or
glo-1 in the mechanosensory neurons by the mec-7 pro-
moter rescued mutant phenotypes in both the ALM and
the PLM neurons, although the rescue was stronger
when expression was driven with the endogenous glo-4
promoter (Figure 6A). However, neither glo-4 nor glo-1
mutant phenotypes were rescued in the ALM or the PLM
neurons when these genes were expressed in muscle
using the myo-3 promoter (Figure 6A). These findings
are consistent with glo-4 and glo-1 acting in a cell-
autonomous fashion in mechanosensory neurons.
To determine if the Glo pathway functions downstream
or upstream of rpm-1, we overexpressed glo-4 or glo-1
Neuron
Regulation of a Vesicular Pathway by RPM-1Figure 6. glo-4 and glo-1 Act Cell-Auto-
nomously Downstream of rpm-1 to
Regulate Axon Termination
(A) Rescue of glo-4 and glo-1 axon termination
phenotypes in ALM neurons. All extrachromo-
somal arrays shown are a single representative
of three or more independently derived lines.
We analyzed young adult animals grown at
22.5C.
(B) Rescue of the PLM hook and extension
phenotype in rpm-1/ mutants by overex-
pression of glo-4 or glo-1. We analyzed young
adult animals grown at 15C. All extrachromo-
somal arrays shown are a single representative
of three or more independently derived lines.
*p < 0.01, **p < 0.005, ***p < 0.001, determined
using Student’s t test.and assessed their ability to rescue rpm-1/ phenotypes
in the mechanosensory neurons. When compared with
rpm-1 mutants or rpm-1 mutants expressing a transgene
with only the mec-7 promoter, overexpression of glo-4 or
glo-1 significantly reduced the PLM hooking and exten-
sion defects in rpm-1 mutants (Figure 6B). We conclude
that glo-4 and glo-1 act downstream of rpm-1 to promote
axon termination.
Late Endosomes at Motor Synapses Are Specifically
Altered in glo-4 Mutants
GLO-4 displayed punctate localization in presynaptic
terminals of motor neurons (Figure 2). In gut cells,
GFP::GLO-1 has been shown to colocalize with FUS-1,
an integral membrane subunit of the vacuolar H+-ATPase
of the late endosome/lysosome (Hermann et al., 2005). We
therefore sought to address whether GLO-4 might regu-
late a specific compartment at synapses. Different Rab
GTPases are known to be associated with specific en-
docytic compartments (Grosshans et al., 2006; Zerial
and McBride, 2001). To explore the localization of these
compartments at synapses, we expressed YFP::RAB-5,
CFP::RAB-7, and CFP::RAB-11 proteins in the DD and
VD motor neurons (see Experimental Procedures); these
RABs are commonly used as markers for the early endo-
some, late endosome, and recycling endosome, respec-
tively. All three RAB markers showed an evenly distrib-Nuted, punctate pattern along the axons (Figures 7A–7C),
and all colocalized with SNB-1::GFP (unpublished data).
This is consistent with observations that the early endo-
cytic machinery is localized at the presynaptic terminal
in other organisms (Leenders et al., 2002; Roos and Kelly,
1999; West et al., 1997). In rpm-1/ mutants, YFP::RAB-
5, CFP::RAB-7, and CFP::RAB-11 were disorganized,
consistent with a general disruption of presynaptic termi-
nals. However, in glo-4/ mutants only CFP::RAB-7
puncta were more diffuse than those in wild-type animals,
whereas YFP::RAB-5 and CFP::RAB-11 were indis-
tinguishable from the wild-type pattern (Figures 7A–
7C). Quantitation of YFP::RAB-5, CFP::RAB-7, and
CFP::RAB-11 puncta showed that all markers had re-
duced numbers of puncta in rpm-1/ mutants, and that
CFP::RAB-7, but not YFP::RAB-5 or CFP::RAB-11,
showed a reduction in glo-4/ mutants (Figures 7D–7F).
These findings imply that glo-4 likely has a specific role
in the formation or accumulation of late endosomes in
neurons.
DISCUSSION
PHR proteins function in the cellular processes that lead to
the precise patterning of axon terminals and the organiza-
tion of synapses in different organisms (Burgess et al.,
2004; D’Souza et al., 2005; Schaefer et al., 2000; Waneuron 55, 587–601, August 16, 2007 ª2007 Elsevier Inc. 595
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Are Altered in glo-4 Mutants
(A, B, and C) Young adult animals with the
indicated genotypes were visualized by con-
focal microscopy for (A) Punc-25CFP::RAB-7
(juEx989) (late endosome), (B) Punc-25
YFP::RAB-5 (juIs199) (early endosome), or (C)
Punc-25CFP::RAB-11 (juIs210) (recycling endo-
some). Shown is a 2D projection of the dorsal
nerve cord. Scale bar, 10 mm.
(D, E, and F) Quantitative analysis of the dorsal
cord of the indicated genotypes for (D)
CFP::RAB-7, (E) YFP::RAB-5, or (F)
CFP::RAB-11. Animals were grown at 25C.
***p < 0.001 was determined using Student’s
t test.et al., 2000; Zhen et al., 2000). A major part of their function
is attributed to their E3 ligase activity in ubiquitin-mediated
protein degradation (Collins et al., 2006; D’Souza et al.,
2005; Nakata et al., 2005; Wu et al., 2005). In particular,
C. elegans RPM-1 and Drosophila Highwire both act to
downregulate the DLK MAPKKK. However, the large
size of the PHR proteins and the presence of several con-
served domains suggest that these proteins have func-
tions that are in addition to, or independent of, a role in
ubiquitination. In this study, using a biochemical approach
to search for RPM-1 interacting proteins, we have uncov-
ered a vesicular trafficking pathway composed of the Rab
GEF GLO-4 and the Rab GLO-1 that is positively regulated
by RPM-1. We show that the GLO pathway acts in parallel
to the F-box protein FSN-1, which mediates RPM-1 ubiq-
uitin ligase activity. Our findings suggest a model in which
RPM-1 promotes the GLO pathway to influence endo-
some trafficking, thereby regulating synapse formation
and axon termination.
GLO-4 Is a Functional Partner of RPM-1
Our mass spectrometric analysis identified the RLD-
containing protein GLO-4 as an RPM-1 interacting pro-
tein. We confirmed the interaction of GLO-4 and RPM-1
in neurons by coimmuniprecipitation (coIP) and colocali-
zation studies. glo-4 mutants were first identified as caus-
ing loss of the gut granules, which are LROs (Hermann
et al., 2005). We find that, in the nervous system, loss of
glo-4 function causes defects that closely resemble, but
are weaker and less penetrant than, those in rpm-1/.596 Neuron 55, 587–601, August 16, 2007 ª2007 Elsevier Inc.rpm-1/ glo-4/ show a similar degree of penetrance
and severity of defects as that in rpm-1/ single mutants.
Like rpm-1, glo-4 function is required in presynaptic neu-
rons. Furthermore, we find that transgenic overexpression
of glo-4 can partially rescue the defects in rpm-1/ mu-
tants. These data are consistent with the conclusion that
GLO-4 acts downstream of RPM-1 to mediate its function
in neurons.
Although the only previously described biochemical
function of RPM-1 is that of a ubiquitin ligase, GLO-4 is
most likely acting independently of that activity for several
reasons. GLO-4 coimmunoprecipitates with a truncated
RPM-1(aa 1–2439) that lacks the RING-finger domain
and a large portion of the C terminus. The localization
and levels of GLO-4::GFP in neurons are not detectably al-
tered in rpm-1/ mutants; nor is the localization of RPM-1
altered in glo-4/ mutants. Moreover, the axon termina-
tion defects in glo-4/ are not suppressed by loss of
function in dlk-1, a known target of RPM-1 ubiquitin ligase
activity. Finally, loss of glo-4 function phenocopies, rather
than suppresses, the rpm-1 defects. These results indi-
cate that the interaction between GLO-4 and RPM-1 is
not required for their synaptic stabilization or localization.
Hence, the RPM-1/GLO-4 interaction is likely to lead to the
activation of the targets of GLO-4, such as the Rab
GTPase GLO-1.
Sequence analysis suggests that GLO-4 and its homol-
ogous proteins have evolved rapidly but have preserved
the RLD as a functional domain. A role for Drosophila
Claret in neurons is not yet known. The vertebrate RPGR
Neuron
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(Hong et al., 2000; Kirschner et al., 2001; Meindl et al.,
1996; Uhlmann et al., 1999). While previous studies
have shown that mutations in RPGR in humans and
mice lead to retinal degeneration and blindness (Hong
et al., 2000; Meindl et al., 1996), it is not known how
RPGR functions in neurons. It will be interesting to re-
examine claret mutants and RPGR/ mice for defects
in synaptic transmission or architecture that may have
gone unnoticed.
RPM-1 Acts through Two Parallel Pathways
to Regulate Axon Termination and Synaptogenesis
rpm-1/ exhibit highly penetrant defects in the mechano-
sensory neurons and the GABAergic motor neurons
(Schaefer et al., 2000; Zhen et al., 2000). Most ALM and
PLM axons overextend beyond their normal termination
sites, either looping back posteriorly or diverting into the
ventral cords, respectively. The PLM synaptic branch
also fails to form. In contrast, the defects in the GABAergic
motor neurons primarily consist of an altered morphology
of SNB-1::GFP puncta and a reduction in puncta number.
These defects are variably and differentially manifested in
mutants of the two binding partners of RPM-1 (Liao et al.,
2004) (this study). For example, glo-4 loss of function
causes ALM axon overextension to a similar degree as
in rpm-1/, but has little discernable abnormality in the
SV compartment or in the active zone in motor neurons.
fsn-1/ shows very weak defects in ALM axon termina-
tion, but strongly affects the SNB-1::GFP puncta in
the DD motor neurons. However, the phenotypes of
fsn-1/; glo-4/ strongly resemble those in rpm-1/
mutants in both mechanosensory neurons and D neurons.
The motor synapse defects in rpm-1/ and fsn-1/ mu-
tants are strongly suppressed by loss of function in dlk-1,
a target of RPM-1’s ubiquitin ligase activity (Nakata et al.,
2005), but the ALM and PLM defects in rpm-1/ and
glo-4/ are partially or not suppressed by dlk-1 loss of
function, respectively (this study). These results are con-
sistent with a conclusion that RPM-1 function occurs
through two parallel genetic pathways, one involving
FSN-1 and another involving GLO-4 (Figure 8). The en-
hancement of phenotypes in fsn-1/; glo-4/ also sug-
gests that despite their biochemical dissimilarity, the
GLO-4 and FSN-1 pathways may have partly redundant
functions.
Our data also show that one target of the RPM-1 and
GLO-4 pathway is GLO-1, the C. elegans member of
the Rab32/Rab38/Rab7L1 GTPase subfamily. glo-1, like
glo-4, was originally identified for its effect on the gut gran-
ules (Hermann et al., 2005). We find that glo-1/ mutants
display touch axon overextension, and that glo-1 interacts
genetically with fsn-1 in a manner similar to glo-4. Studies
on Claret, the Drosophila homolog of GLO-4, have shown
that Claret binds the GDP-bound form of Lightoid (Ma
et al., 2004). As RPM-1 also contains an RLD domain, it
is conceivable that RPM-1 and GLO-4 could act together
as a GEF for GLO-1 in neurons. Our findings that thedefects in glo-1 mutants are weaker than those in glo-4
mutants also implies that other unknown Rab GTPases
function downstream of glo-4 in neurons. The C. elegans
genome encodes >30 Rab proteins; among these we
have not yet identified other Rabs that might act in the
RPM-1 pathway (unpublished data). Mammalian Rab32,
Rab38, and Rab7L1 are all expressed in the brain
(Cohen-Solal et al., 2003; Osanai et al., 2005; Shimizu
et al., 1997). Their evolutionary conservation with GLO-1
suggests that its role in neurons is likely to be conserved.
The different outcomes of RPM-1-mediated signaling in
motor neurons and touch neurons likely reflect both the in-
trinsic differences of the two types of neurons and addi-
tional cues modulating the two parallel pathways. The mo-
tor neuron axons are permissive for synapse formation
along their entire length. The touch neuron axons extend
specific branches to form synapses, presumably in re-
sponse to developmental cues, positional cues, or both.
Although synaptic branch formation is correlated with fur-
ther extension of the longitudinal axons of PLM neurons
(Schaefer et al., 2000), it is yet unclear whether stable syn-
apse formation signals axon termination, or vice versa.
Identifying cues acting differentially on RPM-1/GLO and
RPM-1/FSN-1 will provide insights into these questions.
The GLO Pathway May Promote Trafficking to LROs
Involved in Synaptogenesis and Axon Termination
Given the large body of evidence that the Rab GTPases
function in vesicle trafficking (Collins, 2003; Zerial and
McBride, 2001), the RPM-1/GLO pathway presumably
Figure 8. RPM-1 Functions through Two Parallel Pathways to
Regulate Axon Termination and Synaptogenesis
The C terminus of RPM-1 binds FSN-1 to negatively regulate DLK-1
MAP kinase cascade through ubiquitin-mediated protein degradation.
The N terminus of RPM-1 binds GLO-4 to promote vesicular trafficking
through GLO-1 and AP-3. Both pathways contribute significantly to
RPM-1 function in touch axon termination and motor neuron synapto-
genesis, but the effects of individual cascades are manifested differen-
tially depending upon the cellular context. The MAP kinase cascade
likely acts via regulation of transcription, as shown in Drosophila (Col-
lins et al., 2006). Solid lines represent major signaling routes. Dashed
lines reflect the crosstalk observed from genetic interactions between
the two pathways.Neuron 55, 587–601, August 16, 2007 ª2007 Elsevier Inc. 597
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ficking, or both of certain types of vesicles. RAB-5-, RAB-
7-, and RAB-11-labeled compartments are disorganized
in the motor neuron synapses of rpm-1/ mutants, con-
sistent with the general defects in presynaptic architecture
in these animals. In contrast, glo-4/ mutants exhibit
a specific defect in the late endosomal marker RAB-7,
but have largely normal RAB-5, RAB-11, RIM/UNC-10,
and SNB-1::GFP patterns. This suggests that at least
some of the RAB-7 disorganization in rpm-1/ animals
is due to disruption of the GLO pathway. Drosophila spin-
ster mutants exhibit NMJ defects similar to those in Hiw
mutants, suggesting that these molecules may be func-
tionally related (Wan et al., 2000; Sweeney and Davis,
2002). It is not yet known whether Hiw interacts with Spin-
ster. Nevertheless, these findings suggest a conserved
link between PHR proteins and the regulation of late endo-
somes or postendosome compartments.
The late endosome is a sorting compartment in the en-
docytic pathway, mediating vesicle trafficking to lyso-
somes or the Golgi. The GLO pathway in C. elegans is re-
quired for the formation of gut granules (Hermann et al.,
2005). In contrast, CUP-5 promotes lysosome biogenesis
from late endosome/lysosome hybrid organelles (Fares
and Greenwald, 2001; Treusch et al., 2004), but is not in-
volved in gut granule biogenesis (Hermann et al., 2005).
Our finding of Rpm-1-like defects in glo mutants, but not
in cup-5 mutants, argues that the neuronal phenotypes
of glo mutants do not simply reflect defects in lysosome
function. We show that the GLO pathway in neurons
acts via the AP-3 complex, consistent with gut granule
studies (Hermann et al., 2005). AP-3 is widely known for
its role in the biogenesis of lysosomes and LROs (New-
ell-Litwa et al., 2007). In vertebrate neurons, AP-3 has
been shown to function in SV biogenesis from endosomes
(Blumstein et al., 2001; Faundez et al., 1998; Faundez and
Kelly, 2000; Shi et al., 1998). AP-3-derived vesicles are
present in dendrites, axons, and immature or nascent syn-
apses (Blumstein et al., 2001; Seong et al., 2005). Mice
lacking neuronal AP-3 show a range of synaptic defects,
such as a reduction in SV number (Nakatsu et al., 2004)
and an impairment of presynaptic release in hippocampal
mossy fiber synapses (Scheuber et al., 2006). The obser-
vation that loss of glo-4 function does not dramatically al-
ter SV markers suggests that the GLO/AP-3 pathway may
be redundant with other pathways in SV biogenesis, or
that the SV pool generated by this pathway may be pres-
ent transiently or at low abundance.
Membrane addition and vesicular conversion, or matu-
ration, are essential for neurite extension and synapse as-
sembly. We propose that the local regulation of the GLO
pathway by RPM-1 results in recruitment of AP-3 to spe-
cific vesicular compartments in neurons (Figure 8). The
cellular outcome of this GLO/AP-3-mediated trafficking
may depend on the local environment. In motor synapses,
the GLO/AP-3 pathway may contribute to the delivery and
maturation of synaptic components from precursors,
thereby stabilizing nascent synapses. In touch neurons,598 Neuron 55, 587–601, August 16, 2007 ª2007 Elsevier Inthe GLO/AP-3 pathway may participate in the active cy-
cling of membrane receptors, or vesicle incorporation
into the plasma membrane, to regulate neurite extension.
Active involvement of late endosomes/lysosomes has
recently been implicated in aspects of neuronal morpho-
genesis, such as arborization and pruning of axons or
dendrites (Luo and O’Leary, 2005; Sweeney et al., 2006).
The transient nature of vesicular trafficking presents a
major challenge in elucidating its control in developing
neurons. Future studies on the GLO/AP-3-associated
compartments in neurons will provide clues toward
addressing these questions.
EXPERIMENTAL PROCEDURES
Genetics
C. elegans strains were maintained as described (Brenner, 1974).
Alleles used in this study include the following: rpm-1(ju44), rpm-
1(ju23), glo-4(ok623), glo-1(zu391), glo-1(zu437), fsn-1(hp1), scd-
2(ok565), apm-3(tm920), dlk-1(ju476), cup-5(n3194), and unc-36(e251).
glo-1 and glo-4 mutants were recognized by their lack of gut granules
and partially penetrant dumpy (Dpy) body shape (Hermann et al.,
2005). Deficiency analysis was performed by mating glo-4 males to
the strain BC2617 (dpy-18(e364)/eT1 III; mDf1/eT1 V). mDf1/glo-4 an-
imals had the same penetrance and severity of Glo and Dpy pheno-
types as glo-4 homozygous animals, and no enhanced movement or
body defects. Double mutants were constructed following standard
procedures and confirmed by the associated phenotypes (Glo or Dpy
for glo-1 and glo-4) or by PCR genotyping. Primers and PCR conditions
are available upon request. rpm-1/ glo-4/ were generated by
recombination and linked to the visible marker dpy-11. The transgenic
reporter genes used in this study are as follows: juIs1[Punc-25SNB-
1::GFP] (Hallam and Jin, 1998), juIs58[RPM-1::GFP] (Zhen et al.,
2000), juEx1349[PF25B3.3FLAG::GLO-4], juEx1093[RPM-1(1-2439)::
GFP], juEx1448[Punc-25mcherry::GLO-4], muIs32[Pmec-7GFP] (Pujol
et al., 2000), zdIs5[Pmec-4GFP] (Clark and Chiu, 2003), juEx989-
[Punc-25CFP::RAB-7], juIs199[Punc-25YFP::RAB-5], and juIs201[Punc-25
CFP::RAB-11].
Transgene Constructs
To construct the full-length translational GLO-4::GFP reporter
(juEx1208), a duplex PCR method (Hobert, 2002) was used to fuse
the 9.6 kb glo-4 genomic DNA, including 1.4 kb promoter, with GFP
at the last amino acid of GLO-4 followed by the unc-54 30 UTR (from
pPD95.75, courtesy of A. Fire) using the Expand Long Template
PCR system from Roche. To construct the plasmid pCZ743
(PF25B3.3FLAG::GLO-4), the glo-4 coding region and 0.5 kb of 3
0 UTR
were amplified using primers containing an NheI and a KpnI site at
the 50 and 30 ends, respectively. The PCR product was cloned and
the sequence was confirmed. A FLAG epitope tag was then added
to the N terminus of GLO-4 in an expression vector driven by the pro-
moter of the F25B3.3 gene. To construct cell-type-specific expression
of glo-4 or glo-1, the glo-4 genomic DNA or a glo-1 cDNA from plasmid
pCR2.1 (Hermann et al., 2005) was cloned into the Topo-pCR8 entry
vector (Invitrogen) and recombined into one of three destination vectors
containing themec-7promoter, themyo-3promoter, or theunc-25pro-
moter following the manufacturer’s protocol to generate pCZGY175
(Pmec-7glo-4), pCZGY176 (Pmyo-3glo-4), pCZGY177 (Pmec-7glo-1),
pCZGY178 (Pmyo-3glo-1), and pCZGY398 (Punc-25mcherry::glo-4). The
rab-7 and rab-11 cDNAs in pDONR201 (from B. Grant) were recom-
bined into a destination vector to generate pCZGY168 (Punc-25CFP::
RAB-7) and pCZGY171 (Punc-25CFP::RAB-11). Genomic rab-5 DNA
was amplified by PCR and ligated into an N-terminal YFP expression
vector to generate plasmid pCZ677 (Punc25YFP::RAB-5).c.
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et al., 1991), using N2, muIs32, or rpm-1(ju44); muIs32 animals as
hosts. DNA of interest was injected at 1–5 ng/ml for PCR products,
or 1–10 ng/ml for plasmid DNAs, along with Pttx-3RFP (50 ng/ml) and
pBluescript (50 ng/ml). A minimum of three independent lines were
analyzed.
GFP Analysis and Immunocytochemistry
Analysis of GFP in live animals was carried out using a Zeiss Axioplan 2
microscope equipped with a Chroma HQ-FITC (LP) filter. Live animals
were anesthetized using 1% (v/v) 1-phenoxy-2-propanol in M9 buffer.
Whole-mount staining for anti-SNT-1 and anti-UNC-10 (rabbit), anti-
RPM-1 (rat), and anti-GFP (mouse monoclonal mixture of clones 7.1
and 13.1) was performed as described previously (Nakata et al.,
2005). Anti-SNT-1 and anti-UNC-10 antibodies were provided by
Mike Nonet, anti-RPM-1 antibodies were provided by Benjamin
Abrams, and anti-GFP mouse monoclonal antibody was purchased
from Roche Applied Science. Immunofluorescence images were cap-
tured using a Zeiss LSM 5 PASCAL microscope and PASCAL soft-
ware.
Protein Biochemistry and Mass Spectrometry
Mixed-stage worms were propagated in liquid culture (M9 buffer,
10 mg/ml cholesterol, and HB101 Escherichia coli) in 253 25 cm plastic
trays with gentle rocking at 22.5C–25C. Animals were harvested by
centrifugation (10 s spin at 2000 rpm in a clinical centrifuge) in 15 ml
polystyrene tubes (Fisher Scientific), and washed two or three times
in M9. Contaminating material that pelleted as an upper phase was re-
moved by aspiration, leaving clean, packed, mixed-stage worms.
Packed worms were frozen in liquid N2 and ground using a mortar
and pestle in the presence of EDTA-free protease inhibitor pellets
(Roche). Protein extracts were obtained by adding an equal volume
(relevant to volume of packed starting material) of lysis buffer
(10 mM Tris [pH 7.4], 0.1% NP-40, 10% glycerol, 150 mM NaCl,
1 mM DTT, EDTA-free protease inhibitor pellets, 1 mg/ml pepstatin,
5 mM NaF, 1 mM Na molybdate, 1 mM Na orthovanadate, and 1 mg/ml
mycrocystin). We optimized the extraction of synaptic proteins by
monitoring the detection of neuronal proteins, including synaptobrevin
(SNB-1), SNT-1, DLK-1::GFP, MAX-1::GFP, and RPM-1::GFP (data
not shown). Protein lysates were stirred at 4C for 20 min and cleared
by centrifuging at 16,000 3 g for 20 min, and the cleared supernatant
was used for IP. Protein lysates obtained from approximately 30 ml
(300–400 mg of total protein), or 5–6 ml (40–50 mg of total protein) of
packed, mixed-stage worms were used for mass spectrometry, or
coIP and immunoblotting, respectively (coIP for FLAG::GLO-4 and
RPM-1(1-2439)::GFP was performed from 230 mg of total protein).
Protein lysates were precleared with 50 ml of protein G agarose
(Roche)/25 mg of total protein for 1 hr at 4C with gentle rocking, fol-
lowed by removal of protein G agarose by centrifugation. Anti-GFP
(3E6 mouse monoclonal, Qbiogene) or anti-FLAG antibody (M2 mouse
monoclonal, Sigma) was applied to the supernatant (0.5 mg of 3E6/mg
of total worm protein optimized by titration, 150 mg of anti-FLAG anti-
body/50 mg of total worm protein) in combination with protein G aga-
rose (10 ml/50–75 mg of total worm protein), and soluble immune
complexes were precipitated for 16 hr at 4C with gentle rocking.
Precipitated complexes were washed four times with lysis buffer,
eluted with SDS sample buffer for 10 min at 90C, separated by
SDS-polyacrylamide electrophoresis (PAGE), and subjected to in-gel
tryptic digestion for mass spectrometry or transferred to nitrocellulose
membranes for immunoblotting. For immunoblotting, membranes
were blocked with 5% skim milk, and probed with anti-GFP (1/1000
dilution, mouse monoclonal mixture of clones 7.1 and 13.1, Roche Ap-
plied Science) or anti-FLAG antibody (1/1000 dilution M2 mouse
monoclonal, Sigma). Sheep antibodies coupled to horseradish perox-
idase specific for mouse immunoglobulins were used as secondary
antibodies (applied at 1/15,000 dilution, Roche Diagnostics). Immuno-
blots were developed using Supersignal FemtoWest enhanced chemi-luminescent reagent (Pierce) and visualized by autoradiography with
Biomax Maximum Sensitivity film (Kodak).
For mass spectrometry, the SDS-PAGE gel was fractionated into
five subsamples (corresponding to approximately 10–35 kDa, 40–55
kDa, 60–90 kDa, 90–300 kDa, and higher than 300 kDa) and manually
in-gel digested with trypsin as described previously (Bienvenut et al.,
1999). Digests were analyzed on a SCIEX QSTAR Pulsar (Concord,
Ontario, Canada) with a nanoelectrospray source and interfaced to
an LC-Packings Ultimate (Amsterdam, Holland) HPLC system using
acquisition parameters described previously (Owen et al., 2005). Tan-
dem mass spectra were extracted using the script Mascot.dll 1.6b4
(Matrix Science, London) and used to search the C. elegans subset
of the UNIPROT-KB database (02/2006 release) with MASCOT 2.0
(www.matrixscience.com; Perkins et al., 1999) applying the standard
(non ‘‘MUDPIT’’) scoring scheme. Validation was manual, with only
proteins matched by at least two peptides accepted. Lists of identified
proteins for the negative control sample and the pull-down experiment
were aligned, and all proteins in the pull-down found in common with
the negative control were considered nonspecific and removed. Our
mass spectrometric analysis identified more than 14 different peptides
from the 90–300 kDa size fraction encoded by the open reading frames
F07C3.4 and F07C3.5. These reading frames are directly adjacent to
one another and were subsequently reannotated by Wormbase as
a single open reading frame, F07C3.4, encoding the complete glo-4
gene.
Supplemental Data
Supplemental data includes two figures that can be found online with
this article at http://www.neuron.org/cgi/content/full/55/4/587/DC1/.
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